Registered Malawi · PMRA

BIOPLUS-STRAWBERRY COMBINATION PRODUCT SYRUP

MULTI-COMPONENT

PMPB/PL1/90 SYRUP

What it does

This medication is a combination of different ingredients that work together to treat various conditions.

Commonly used for: relief of pain, fever reduction, inflammation control

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
PMPB/PL1/90
Registration date
27/04/2012
Expiry date
30/06/2019
Status
Registered
Active ingredient
MULTI-COMPONENT
Dosage form
SYRUP
Strength
-
Pack size
-
Therapeutic class
-
Manufacturer / MAH
-
Applicant / LTR
-
Country of origin
-

Source: Pharmacy and Medicines Regulatory Authority · fetched 2026-04-21 17:37:38 · updated 2026-09-29 04:33:03

Disclaimer: This information is sourced from Pharmacy and Medicines Regulatory Authority (Malawi). Always consult a qualified healthcare professional before using any medication.

About this medicine

This medication is a combination of different ingredients that work together to treat various conditions.

What it treats

  • relief of pain
  • fever reduction
  • inflammation control

How it works

The different components in this medication target specific symptoms or conditions, helping to relieve discomfort and improve your overall health.

Who it's for

This medication is suitable for adults and children, depending on the specific components and their indications.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: multicomponent

Multicomponent drugs refer to pharmaceutical formulations that contain more than one active ingredient, each contributing to the therapeutic effect. These combinations are designed to enhance efficacy, reduce dosages of individual components, or minimize side effects. Multicomponent therapies are often used to treat complex conditions, such as hypertension or diabetes, where multiple physiological pathways need to be addressed simultaneously.

Indications

  • Hypertension
  • Diabetes Mellitus
  • Chronic Pain
  • Cardiovascular diseases
  • Respiratory conditions

Dosage

Children: Refer to specific product guidelines or clinical pharmacology resources for pediatric dosing information, as this will depend on the formulation and individual components.

Adults: Refer to specific product guidelines or clinical pharmacology resources for dosing information, as it can vary widely based on the combination and indication.

Mechanism of action

The mechanism of action of multicomponent drugs varies depending on the specific active ingredients included. Each component may have its own distinct pathway, which can include receptor antagonism, enzyme inhibition, or modulation of neurotransmitter levels. For example, in a combination antihypertensive treatment, one component may act as a diuretic to reduce blood volume, while another may block angiotensin II receptors to decrease vascular resistance.

Pharmacodynamics

Pharmacodynamics of multicomponent drugs is influenced by the synergistic or additive effects of the active ingredients. This can lead to enhanced therapeutic benefits while potentially reducing adverse effects. The interaction between components can also modify the overall efficacy, making it essential to understand the pharmacological profile of each ingredient and the intended therapeutic outcome.

Pharmacokinetics

The pharmacokinetics of multicomponent drugs is complex, as it involves the absorption, distribution, metabolism, and excretion of multiple active substances. Each ingredient may have different pharmacokinetic properties, affecting the overall bioavailability and half-life of the formulation. Drug interactions must be considered, as one component can influence the metabolism of another, impacting therapeutic levels and safety.

Pregnancy

The safety of multicomponent therapies during pregnancy varies by the components used. It is essential to assess individual components for safety and potential risks.

Breast-feeding

The effects of multicomponent therapies during breastfeeding depend on the specific components. Consultation with healthcare professionals is recommended to evaluate safety.

Storage

Store in a cool, dry place away from direct sunlight. Specific storage requirements may vary based on individual components.

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.